A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects
Revision as of 08:49, 13 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects; S Azarbar, A Salardini, N Dahdah, J Lazewatskyae; 2015; doi_citing_unknown == Retraction == Simultaneous test of ventricular function and myocardial perfusion during exercise with a new agent labelled with Tc99m ; N Pérez Baliño V Sporn L L Holman A Sosa Liprandi O Masoli A Mitta L Camin S Castiglia K McK; 01/01/1987...")
Target ArticleEdit
A phase I-II, open-label, multicenter trial to determine the dosimetry and safety of 99mTc-Sestamibi in pediatric subjects; S Azarbar, A Salardini, N Dahdah, J Lazewatskyae; 2015; doi_citing_unknown
RetractionEdit
Simultaneous test of ventricular function and myocardial perfusion during exercise with a new agent labelled with Tc99m ; N Pérez Baliño V Sporn L L Holman A Sosa Liprandi O Masoli A Mitta L Camin S Castiglia K McK; 01/01/1987
- doi_cited_unknown
Citation pieceEdit
Note: Open to append information.